OTCMKTS:CHEOY - Cochlear Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$87.49
▲ +0.25 (0.29%)
1 month | 3 months | 12 months
Get New Cochlear Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHEOY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHEOY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $87.49.
Sell
The current consensus among 1 polled investment analysts is to sell stock in Cochlear. This rating has held steady since February 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 2 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 2 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
1/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/22/2021CitigroupDowngradeNeutral ➝ Sell
i
1/21/2021CitigroupUpgradeSell ➝ Neutral
i
3/17/2020CitigroupUpgradeSell ➝ Neutral
i
3/12/2020Jefferies Financial GroupUpgradeUnderperform ➝ Hold
i
2/20/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell
i
2/18/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight
i
1/22/2020Jefferies Financial GroupDowngradeHold ➝ Underperform
i
10/21/2019Jefferies Financial GroupInitiated CoverageHold
i
7/17/2019CitigroupDowngradeNeutral ➝ Sell
i
4/16/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy
i
3/5/2019CitigroupUpgradeNeutral ➝ Buy
i
(Data available from 4/18/2016 forward)
Cochlear logo
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More

Today's Range

Now: $87.49
$86.57
$87.75

50 Day Range

MA: $81.79
$77.41
$87.30

52 Week Range

Now: $87.49
$55.66
$89.36

Volume

6,155 shs

Average Volume

2,967 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Cochlear?

The following equities research analysts have issued stock ratings on Cochlear in the last year: Citigroup Inc..
View the latest analyst ratings for CHEOY.

What is the current price target for Cochlear?

0 Wall Street analysts have set twelve-month price targets for Cochlear in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cochlear in the next year.
View the latest price targets for CHEOY.

What is the current consensus analyst rating for Cochlear?

Cochlear currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe CHEOY will underperform the market and that investors should sell shares of Cochlear.
View the latest ratings for CHEOY.

What other companies compete with Cochlear?

How do I contact Cochlear's investor relations team?

The company's listed phone number is 61 2 9428 6555. The official website for Cochlear is www.cochlear.com.